Reaction of the glucose carrier of erythrocytes with sodium tetrathionate: evidence for inward-facing and outward-facing carrier conformations.
Sodium tetrathionate reacts with the glucose carrier of human erythrocytes at a rate which is greatly altered in the presence of competitive inhibitors of glucose transport. Inhibitors bound to the carrier on the outer surface of the membrane, either at the substrate site (maltose) or at the external inhibition site (phloretin and phlorizin), more than double the reaction rate. Inhibitors bound at the internal inhibition site (cytochalasin B and androstenedione), protect the system against tetrathionate. After treatment with tetrathionate, the maximum transport rate falls to less than one-third, and the properties of the binding sites are modified in unexpected ways. The affinity of externally bound inhibitors rises: phloretin is bound up to seven times more strongly and phlorizin and maltose twice as strongly. The affinity of cytochalasin B, bound at the internal inhibition site, falls to half while that of androstenedione is little changed. The affinity of external glucose falls slightly. Androstenedione prevents both the fall in transport activity and the increase in phloretin affinity produced by tetrathionate. An inhibitor of anion transport has no effect on the reaction. The observations support the following conclusions: Tetrathionate produces its effects on the glucose transport system by reacting with the carrier on the outer surface of the membrane. The carrier assumes distinct inward-facing and outward-facing conformations, and tetrathionate reacts with only the outward-facing form. The thiol group with which tetrathionate is presumed to react is not present in either the substrate site or the internal or external inhibitor site.(ABSTRACT TRUNCATED AT 250 WORDS)
D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D000735:Androstenedione / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D008320:Maltose / Q000494:pharmacology; D008433:Mathematics; D009004:Monosaccharide Transport Proteins; D010693:Phloretin / Q000494:pharmacology; D011487:Protein Conformation; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013776:Tetrathionic Acid / Q000494:pharmacology*; D013885:Thiosulfates / Q000494:pharmacology*; D013997:Time Factors
D002352:Carrier Proteins; D009004:Monosaccharide Transport Proteins; D013439:Sulfhydryl Reagents; D013885:Thiosulfates; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D000735:Androstenedione; D008320:Maltose; D013776:Tetrathionic Acid; D010693:Phloretin